RF1AG093116
Project Grant
Overview
Grant Description
MOLECULAR MECHANISMS AND GENETIC BASIS OF HUMAN OVARIAN AGING - THIS RESEARCH PROPOSAL IS IN RESPONSE TO THE NOT-OD-24-079 “NOTICE OF SPECIAL INTEREST: WOMEN’S HEALTH RESEARCH” FOCUSED ON HEALTH CONDITIONS THAT ARE FEMALE-SPECIFIC. THE OVARY IS THE FIRST ORGAN TO AGE IN THE HUMAN BODY. OVARIAN AGING NEGATIVELY INFLUENCES LIFESPAN AND A BROAD RANGE OF HEALTH OUTCOMES IN CARDIOVASCULAR, SKELETAL, METABOLIC, IMMUNE, AND NEUROCOGNITIVE SYSTEMS IN WOMEN. HOWEVER, AS WITH SO MANY ASPECTS OF WOMEN’S HEALTH, OVARIAN AGING HAS RECEIVED LIMITED SCIENTIFIC ATTENTION, EVEN IN LARGE GENOMIC SURVEY PROJECTS, AND THE BIOLOGICAL MECHANISMS UNDERLYING HUMAN OVARIAN AGING AND THAT MAY HAVE BROAD IMPLICATIONS FOR WOMEN’S HEALTHSPAN REMAIN POORLY UNDERSTOOD. THE OBJECTIVE OF THIS PROPOSAL IS TO INVESTIGATE THE MOLECULAR MECHANISMS THAT CONTROL THE REMARKABLY COMPLEX PROCESSES OF OVARIAN AGING AND THAT ARE CAUSALLY LINKED TO HUMAN GENETIC FACTORS INFLUENCING OVARIAN AGING. IN OUR PRELIMINARY STUDIES, BY PERFORMING A COUPLED SINGLE NUCLEUS (SN)RNA-SEQ AND SNATAC-SEQ (ASSAY FOR TRANSPOSASE-ACCESSIBLE CHROMATIN USING SEQUENCING) ANALYSIS OF FLASH-FROZEN OVARY TISSUES FROM YOUNG (AGE 20S) AND REPRODUCTIVELY OLD (AGE ~50S) WOMEN, WE MADE AN INTERESTING DISCOVERY THAT AGING IN THE OVARY PROCEEDS THROUGH THE CONSERVED HALLMARK PATHWAYS OF AGING IN EACH CELL TYPE, SUCH AS ACTIVATION OF MTOR SIGNALING, BUT IN AN ACCELERATED MANNER COMPARED TO OTHER HUMAN TISSUE TYPES, AND THERE IS A REMARKABLE COORDINATION OF TRANSCRIPTOME AND REGULATORY CHANGES ACROSS ALL CELL TYPES IN THE OVARY. THESE FINDINGS RAISE THE HOPE THAT KNOWN GEROPROTECTORS THAT TARGET THE HALLMARKS OF AGING CAN BE USED TO DELAY AGING IN THE OVARY IN WOMEN. HOWEVER, THEY ALSO RAISE IMPORTANT NEW QUESTIONS: HOW EARLY AGING STARTS IN THE OVARY WHICH IS IMPORTANT TO UNDERSTAND IF WE WANT TO DELAY OVARIAN AGING AND ITS NEGATIVE HEALTH OUTCOMES; AND WHAT MECHANISMS UNDERLIE THE DYNAMIC AND COORDINATED TRANSCRIPTIONAL AND REGULATORY CHANGES IN THE OVARY AND HOW THEY INFLUENCE INTERACTIONS BETWEEN OOCYTES AND THEIR SURROUNDING SOMATIC CELLS DURING OVARIAN AGING. FURTHERMORE, WE FOUND THAT THE GREAT MAJORITY (94%) OF THE GENETIC VARIANTS ASSOCIATED WITH AGE AT NATURAL MENOPAUSE (ANM), A PROXY FOR FEMALE REPRODUCTIVE AGING, AS WELL AS A TRUSTWORTHY INDICATOR OF POSTMENOPAUSAL HEALTH, RESIDE IN NON-CODING REGIONS OF THE GENOME, INDICATING THAT REGULATORY CHANGES CONTRIBUTE TO OVARIAN AGING. HOWEVER, ELUCIDATING THE FUNCTIONAL ROLE OF THESE NON-CODING REGULATORY VARIANTS AND IDENTIFICATION OF THEIR TARGET GENES IS CHALLENGING AND DIFFICULTIES IN GWAS INTERPRETATION HAS BEEN THE MAJOR BARRIER TO UNDERSTANDING THE GENETIC BASIS OF OVARIAN AGING IN WOMEN AND TRANSLATION OF HUMAN GENETIC DISCOVERY. BY ADDRESSING THE NEW QUESTIONS AND FILLING THE KNOWLEDGE GAPS IN THE MOLECULAR MECHANISMS AND GENETIC BASIS OF HUMAN OVARIAN AGING THROUGH INTEGRATED IN SILICO ANALYSIS AND UNBIASED GENOMIC PROFILING AT SINGLE CELL LEVEL, AND CRISPR-MEDIATED GENOME EDITING AND DATA-DRIVEN FUNCTIONAL ASSAYS, OUR LONG-TERM GOAL IS TO DEFINE AND VALIDATE REGULATORY DRIVERS OF THE “PREMATURE” AGING IN THE OVARY AND IDENTIFY POTENTIAL TARGETS FOR THERAPEUTIC INTERVENTIONS IN WOMEN.
Funding Goals
TO ENCOURAGE BIOMEDICAL, SOCIAL, AND BEHAVIORAL RESEARCH AND RESEARCH TRAINING DIRECTED TOWARD GREATER UNDERSTANDING OF THE AGING PROCESS AND THE DISEASES, SPECIAL PROBLEMS, AND NEEDS OF PEOPLE AS THEY AGE. THE NATIONAL INSTITUTE ON AGING HAS ESTABLISHED PROGRAMS TO PURSUE THESE GOALS. THE DIVISION OF AGING BIOLOGY EMPHASIZES UNDERSTANDING THE BASIC BIOLOGICAL PROCESSES OF AGING. THE DIVISION OF GERIATRICS AND CLINICAL GERONTOLOGY SUPPORTS RESEARCH TO IMPROVE THE ABILITIES OF HEALTH CARE PRACTITIONERS TO RESPOND TO THE DISEASES AND OTHER CLINICAL PROBLEMS OF OLDER PEOPLE. THE DIVISION OF BEHAVIORAL AND SOCIAL RESEARCH SUPPORTS RESEARCH THAT WILL LEAD TO GREATER UNDERSTANDING OF THE SOCIAL, CULTURAL, ECONOMIC AND PSYCHOLOGICAL FACTORS THAT AFFECT BOTH THE PROCESS OF GROWING OLD AND THE PLACE OF OLDER PEOPLE IN SOCIETY. THE DIVISION OF NEUROSCIENCE FOSTERS RESEARCH CONCERNED WITH THE AGE-RELATED CHANGES IN THE NERVOUS SYSTEM AS WELL AS THE RELATED SENSORY, PERCEPTUAL, AND COGNITIVE PROCESSES ASSOCIATED WITH AGING AND HAS A SPECIAL EMPHASIS ON ALZHEIMER'S DISEASE. SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM: TO EXPAND AND IMPROVE THE SBIR PROGRAM, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, TO INCREASE SMALL BUSINESS PARTICIPATION IN FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION. SMALL BUSINESS TECHNOLOGY TRANSFER (STTR) PROGRAM: TO STIMULATE AND FOSTER SCIENTIFIC AND TECHNOLOGICAL INNOVATION THROUGH COOPERATIVE RESEARCH DEVELOPMENT CARRIED OUT BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO FOSTER TECHNOLOGY TRANSFER BETWEEN SMALL BUSINESS CONCERNS AND RESEARCH INSTITUTIONS, TO INCREASE PRIVATE SECTOR COMMERCIALIZATION OF INNOVATIONS DERIVED FROM FEDERAL RESEARCH AND DEVELOPMENT, AND TO FOSTER AND ENCOURAGE PARTICIPATION OF SOCIALLY AND ECONOMICALLY DISADVANTAGED SMALL BUSINESS CONCERNS AND WOMEN-OWNED SMALL BUSINESS CONCERNS IN TECHNOLOGICAL INNOVATION.
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
New York
United States
Geographic Scope
State-Wide
Related Opportunity
The Trustees Of Columbia University In The City Of New York was awarded
Genetic Basis of Ovarian Aging in Women
Project Grant RF1AG093116
worth $3,445,585
from National Institute on Aging in September 2025 with work to be completed primarily in New York United States.
The grant
has a duration of 4 years and
was awarded through assistance program 93.866 Aging Research.
The Project Grant was awarded through grant opportunity NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 9/5/25
Period of Performance
9/1/25
Start Date
8/31/29
End Date
Funding Split
$3.4M
Federal Obligation
$0.0
Non-Federal Obligation
$3.4M
Total Obligated
Activity Timeline
Additional Detail
Award ID FAIN
RF1AG093116
SAI Number
RF1AG093116-1404772683
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Private Institution Of Higher Education
Awarding Office
75NN00 NIH National Insitute on Aging
Funding Office
75NN00 NIH National Insitute on Aging
Awardee UEI
QHF5ZZ114M72
Awardee CAGE
3FHD3
Performance District
NY-90
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Modified: 9/5/25